Immunotherapy Committee (ITH)

The ITH Committee has been created to assist in the development and clinical application of immunotherapy in the treatment of cancer and infectious diseases with special emphasis on the developing world.

What is the ITH?

The IUIS Immunotherapy Committee (ITH) has been created to assist in the development and clinical application of immunotherapy in the treatment of cancer and infectious diseases with special emphasis on the developing world. 

Remit includes:
  1. Develop policy positions on the application of new immune therapy approaches in cancer and infectious diseases
  2. Communication with other organizations devoted the supporting immunotherapy (i.e. SITC; joint projects)
  3. Sponsor public and academic education on immune therapy issues

Resources

Listen to a BBC5 radio interview on T-cell related discoveries:
http://www.thenakedscientists.com/HTML/specials/show/20160224/


Back to Committees

More Committees

Clinical Immunology Committee (CIC)

Publications Committee (PUB)

Inborn Errors of Immunity Committee (IEI)

Vaccine Committee (VAC)

Nomenclature Committee (NOM)

Executive Committee

Veterinary Immunology Committee (VIC)

Gender Equality and Career Development Committee (GEC)

Quality Assessment and Standardization Committee (QAS)